Zinexts Life Science Corporation
Languages
English
繁體中文
  • About
  • Technologies
  • Solutions
  • Services
  • Downloads
  • Contact
    • Careers
    • Location
    • Investor
Languages
English
繁體中文


Assay Techniques and Test Development for COVID-19 Diagnosis

  • Home
  • Latest News
  • Latest News

Assay Techniques and Test Development for COVID-19 Diagnosis

An ongoing theme of the COVID-19 pandemic is the need for widespread availability of accurate and efficient diagnostic testing for the detection of SARS-CoV-2 and antiviral antibodies in infected individuals. This report describes various assay techniques and tests for COVID-19 diagnosis. Most tests for early detection of SARS-CoV-2 RNA rely on the reverse transcription-polymerase chain reaction, but isothermal nucleic acid amplification assays, including transcription-mediated amplification and CRISPR-based methodologies, are promising alternatives. Identification of individuals who have developed antibodies to the SARS-CoV-2 virus requires serological tests, including enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay. This report also provides an overview of current development in COVID-19 diagnostic techniques and products to facilitate future improvement and innovation.

 
Back to the top
→ Partner Login
→ Investor
→ Latest News
→ Careers

Zinexts Life Science Corp.

  •   Address: 16F., No. 93, Sec. 1, Xintai 5th Rd.,
                 Xizhi Dist., New Taipei City 221416,
                 Taiwan (R.O.C)
  •   Tel: +886 2 2246 3579 ext. 671
     Fax: +886 2 2243 8570
  •  General Inquiries: info@zinexts.com
  •  Sales Inquiries: sales@zinexts.com
 Privacy Policy                                               
 

Copyright © 2022 All rights reserved Zinexts Life Science and Technology 

→ Partner Login
→ Investor
→ Latest News
→ Careers
GO
Sent
>Cancel
Design by WebTech Webpage design